Can a malignant ovarian carcinoma presenting with ascites and pleural effusion be classified as pseudo-Meigs syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pseudo-Meigs Syndrome vs. Meigs Syndrome

Yes, pseudo-Meigs syndrome is essentially "Meigs but with malignant ovarian cancer" – it presents with the same triad of ovarian tumor, ascites, and pleural effusion, but the ovarian tumor is malignant rather than benign.

Key Distinction

Meigs syndrome is defined as:

  • Benign ovarian tumor (typically fibroma, thecoma, or Brenner tumor)
  • Ascites
  • Pleural effusion
  • Complete resolution of ascites and pleural effusion after tumor removal 1, 2

Pseudo-Meigs syndrome is defined as:

  • Malignant ovarian tumor (primary ovarian carcinoma or metastatic disease to the ovary)
  • Ascites and/or pleural effusion
  • Resolution or improvement of effusions after tumor removal 3, 4, 5

Critical Clinical Points

Staging Implications

When a malignant ovarian tumor presents with pleural effusion, this automatically classifies the disease as FIGO Stage IV if the pleural fluid cytology is positive for malignant cells 6, 7, 6, 7, 8. However, in true pseudo-Meigs syndrome, the pleural fluid and ascites are typically negative for malignant cells despite the presence of malignancy 4, 5, 9, 10.

The Diagnostic Challenge

The presence of ascites, pleural effusion, and elevated CA-125 with an ovarian mass strongly suggests malignancy 1, 11. This creates a diagnostic dilemma because:

  • If cytology is positive → Stage IV ovarian cancer (not pseudo-Meigs)
  • If cytology is negative → Could be pseudo-Meigs syndrome with malignant tumor

Common Pitfall

Do not assume all pleural effusions and ascites with ovarian malignancy represent peritoneal/pleural metastases. In pseudo-Meigs syndrome, these effusions resolve after oophorectomy because they result from the tumor's mechanical or hormonal effects rather than direct metastatic spread 3, 4, 5, 9.

Clinical Significance

Pseudo-Meigs syndrome most commonly occurs with:

  • Primary ovarian carcinomas (particularly serous carcinoma) 3
  • Krukenberg tumors (metastatic disease to ovary, especially from gastric or colorectal cancer) 4, 5, 9

Surgical removal of the ovarian tumor leads to rapid resolution of ascites and pleural effusion in both Meigs and pseudo-Meigs syndromes 3, 4, 5, 9, 10. This distinguishes pseudo-Meigs from true Stage IV disease with malignant effusions, where fluid would persist or recur after surgery.

Bottom Line

The term "pseudo-Meigs" acknowledges that while the clinical presentation mimics Meigs syndrome (benign tumor with effusions), the underlying pathology is malignant. The key is that the effusions are not due to malignant seeding but rather to the tumor's presence, which is why they resolve with tumor removal.

References

Research

Giant Ovarian Thecoma Associated with Meigs Syndrome: A Striking Case.

Chirurgia (Bucharest, Romania : 1990), 2021

Guideline

surgery for ovarian cancer: rationale and guidelines.

Journal of the National Comprehensive Cancer Network : JNCCN, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.